Zusammenfassung
Bei der Herzinsuffizienz handelt es sich um ein häufiges Krankheitsbild in der Kardiologie, welches maßgeblichen Einfluss auf die Prognose der Patienten hat. Die Herzinsuffizienz wird nach heutigem Verständnis in 3 Entitäten unterteilt: Herzinsuffizienz mit reduzierter Ejektionsfraktion („heart failure with reduced ejection fraction“; HFrEF); Herzinsuffizienz mit mäßiggradig reduzierter Ejektionsfraktion („heart failure with mildly reduced ejection fraction“; HFmrEF); Herzinsuffizienz mit erhaltener Ejektionsfraktion („heart failure with preserved ejection fraction“; HFpEF). Das vorliegende Kapitel erläutert die Diagnostik der Herzinsuffizienz und die Therapie der unterschiedlichen Formen der Herzinsuffizienz entsprechend der aktuellen Leitlinien.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Anker SD, Butler J, Filippatos G et al (2021) Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med 385:1451–1461
Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J et al (2020) Vericiguat in patients with heart failure and reduced ejection fraction. N Engl J Med 382(20):1883–1893
Brouwers FP, de Boer RA, van der Harst P et al (2013) Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J 34:1424–1431
Conrad N, Judge A, Tran J et al (2018) Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet 391:572–580
Dunlay SM, Roger VL, Weston SA, Jiang R, Redfield MM (2012) Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction. Circ Heart Fail 5:720–726
Edelmann F, Gelbrich G, Düngen HD et al (2011) Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. J Am Coll Cardiol 58:1780–1791
Gerber Y, Weston SA, Redfield MM et al (2015) A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med 175:996–1004
Gheorghiade M, De Luca L, Fonarow GC, Filippatos G, Metra M, Francis GS (2005) Pathophysiologic targets in the early phase of acute heart failure syndromes. Am J Cardiol 96:11g–17g
McDonagh TA, Metra M, Adamo M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599–3726
Meyer S, Brouwers FP, Voors AA et al (2015) Sex differences in new-onset heart failure. Clin Res Cardiol 104:342–350
Omar W, Pandey A, Haykowsky MJ, Berry JD, Lavie CJ (2018) The evolving role of cardiorespiratory fitness and exercise in prevention and management of heart failure. Curr Heart Fail Rep 15:75–80
Pieske B, Tschöpe C, de Boer RA et al (2019) How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J 40:3297–3317
Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BA (2018) A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation 138:861–870
Tsao CW, Lyass A, Enserro D et al (2018) Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction. JACC Heart Fail 6:678–685
Zannad F, Ferreira JP, Pocock SJ et al (2020) SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials. Lancet 396:819–829
Zois NE, Bartels ED, Hunter I, Kousholt BS, Olsen LH, Goetze JP (2014) Natriuretic peptides in cardiometabolic regulation and disease. Nat Rev Cardiol 11:403–412
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Schütt, K. (2023). Chronische Herzinsuffizienz. In: Marx, N., Erdmann, E. (eds) Klinische Kardiologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-62932-1_20
Download citation
DOI: https://doi.org/10.1007/978-3-662-62932-1_20
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-62931-4
Online ISBN: 978-3-662-62932-1
eBook Packages: Medicine (German Language)